Browsing Category
Healthcare Industry News
2815 posts
Roche (SIX: ROP) sales rise 7% as pipeline hopes meet a near-record valuation
Roche delivered 7% constant-currency Q3 sales growth and maintained 2026 guidance as newer medicines offset patent erosion. With ROP touching a 52-week high and key medicines still awaiting regulatory decisions, pipeline conversion is becoming the next valuation test.
Confido Health secures $22.5m Series A funding as CareOS moves beyond voice AI
Confido Health is expanding CareOS from voice-based patient communication into an integrated administrative AI platform, backed by $22.5 million in Series A financing and growing adoption among multi-site medical groups.
Fractyl Health just hit a pivotal endpoint. Why is it cutting 45% of its workforce?
Fractyl Health is eliminating roughly 45% of its workforce and ending internal Rejuva development despite positive pivotal Revita data, concentrating a shrinking cash runway around one obesity programme and a late-2026 FDA filing.
Abbott plans $8.5bn Nutrition spin-off as growth forecast drops to about 6%
Abbott plans to separate its $8.5 billion Nutrition operation by the end of 2027, leaving a roughly $42 billion healthcare company focused on devices, diagnostics and medicines while investors weigh portfolio simplification against weaker near-term growth expectations.
EQT offers €46.50 for QIAGEN in $10.8bn deal, but which takeover premium matters?
EQT has agreed a €46.50-per-share cash takeover of QIAGEN, valuing the molecular diagnostics group at about €9.6 billion, but the deal’s apparently conflicting takeover premiums reveal how months of acquisition speculation had already moved the stock.
Abbott sales reach $13bn as Exact Sciences deal drives 47% diagnostics growth
Abbott Laboratories reported third-quarter revenue of $13.01 billion, supported by the acquisition of Exact Sciences and growth in cardiovascular and diabetes technologies. However, slower medical device momentum and a cautious annual outlook weighed on investor sentiment.
Sigma Healthcare reports 12.1% Chemist Warehouse sales growth as international stores surge 30.2%
Sigma Healthcare has reported strong Chemist Warehouse-branded store sales growth across Australia and international markets, with beauty, healthcare and GLP-1-related products supporting demand while discretionary categories remain under pressure.
Integra LifeSciences earnings rebound as $2.1bn refinancing strengthens finances despite manufacturing setbacks
Integra LifeSciences returns to profit and refinances $2.1 billion in debt. Explore Q3 earnings, manufacturing setbacks and investor risks.
Myriad Genetics stock surges as Labcorp buys prenatal testing business for $210m
Myriad Genetics is selling its prenatal testing business to Labcorp for $210 million. See why $MYGN surged and what the deal means for both companies.
EBR Systems seeks Australian approval for WiSE wireless heart pacing device after US launch
EBR Systems has submitted its WiSE cardiac pacing system for Australian regulatory inclusion following an earlier priority review determination, potentially opening a second commercial market while the company's United States implant rollout continues at a slower pace than previously anticipated.